New Carbidopa/Levodopa Formulation Approved for Reducing OFF Time Amneal Pharmaceuticals, Inc. announced today that their new medication IPX203, now known as...see more
VICTORY FOR THE PARKINSON’S DISEASE COMMUNITY: THE NATIONAL PLAN TO END PARKINSON’S ACT IS NOW LAW
It’s official: The...see more
WHAT’S HAPPENING AT APDA
Join us for an Optimism Walk! We’ve got a fantastic fall schedule of APDA Optimism...see more
LEGOS FOR PARKINSON’S
As part of the FIRST* LEGO® League program, a group of students (11–13-year-olds) from South Carolina...see more
“ASK THE DOCTOR” WITH DR. REBECCA GILBERT
Q: I always seem to be nauseous. Are there treatments for this?...see more
THE RISE OF BIOMARKER TECHNOLOGY IN PARKINSON’S DISEASE
A biomarker is a clue inside the body that indicates that...see more
AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON’S ACT BECOMING LAW
APDA remains steadfast in its mission to support those impacted by Parkinson’s disease as new law provides hope for...see more
Historic News for the PD Community
The National Plan to End Parkinson’s Act Has Been Signed into Law Today we celebratethe President’s signing of the...see more
AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES NEW RESOURCES AVAILABLE IN MANDARIN & SIMPLIFIED CHINESE
APDA is Committed to Reaching & Supporting More People with Parkinson’s Disease NEW YORK, NY, JUNE 24, 2024 –...see more
Understanding levodopa-induced dyskinesias: APDA-funded research published
Congratulations to our 2020 APDA Research Grant Awardee Dr. Karen Jaunarajs for her work on understanding levodopa induced dyskinesias....see more